AAAAAA

   
Results: 1-25 |
Results: 25
Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and G alpha protein subunits
Authors: Wurch, T Pauwels, PJ
Citation: T. Wurch et Pj. Pauwels, Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and G alpha protein subunits, J PHARM TOX, 45(1), 2001, pp. 3-16
Different regulation of RGS2 mRNA by haloperidol and clozapine
Authors: Robinet, EA Wurch, T Pauwels, PJ
Citation: Ea. Robinet et al., Different regulation of RGS2 mRNA by haloperidol and clozapine, NEUROREPORT, 12(8), 2001, pp. 1731-1735
Modulation of 5-HT1A receptor activation by its interaction with wild-typeand mutant G(alpha i3) proteins
Authors: Dupuis, DS Wurch, T Tardif, S Colpaert, FC Pauwels, PJ
Citation: Ds. Dupuis et al., Modulation of 5-HT1A receptor activation by its interaction with wild-typeand mutant G(alpha i3) proteins, NEUROPHARM, 40(1), 2001, pp. 36-47
Analysis of ligand activation of alpha(2)-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry
Authors: Pauwels, PJ Wurch, T Tardif, S Finana, F Colpaert, FC
Citation: Pj. Pauwels et al., Analysis of ligand activation of alpha(2)-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry, N-S ARCH PH, 363(5), 2001, pp. 526-536
Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein
Authors: Wurch, T Okuda, J Pauwels, PJ
Citation: T. Wurch et al., Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein, MOLEC PHARM, 60(4), 2001, pp. 666-673
Dynamic dopamine-antagonist interactions at recombinant human dopamine D-2short receptor: Dopamine-bound versus antagonist-bound receptor states
Authors: Pauwels, PJ Finana, F Tardif, S Wurch, T Colpaert, FC
Citation: Pj. Pauwels et al., Dynamic dopamine-antagonist interactions at recombinant human dopamine D-2short receptor: Dopamine-bound versus antagonist-bound receptor states, J PHARM EXP, 297(1), 2001, pp. 133-140
Agonist-independent and -dependent oligomerization of doparnine D-2 receptors by fusion to fluorescent proteins
Authors: Wurch, T Matsumoto, A Pauwels, PJ
Citation: T. Wurch et al., Agonist-independent and -dependent oligomerization of doparnine D-2 receptors by fusion to fluorescent proteins, FEBS LETTER, 507(1), 2001, pp. 109-113
Real-time analysis of dopamine: antagonist interactions at recombinant human D-2long receptor upon modulation of its activation state
Authors: Pauwels, PJ Tardif, S Wurch, T Colpaert, FC
Citation: Pj. Pauwels et al., Real-time analysis of dopamine: antagonist interactions at recombinant human D-2long receptor upon modulation of its activation state, BR J PHARM, 134(1), 2001, pp. 88-97
Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT1B receptor
Authors: Bhalla, P Sharma, HS Ma, XQ Wurch, T Pauwels, PJ Saxena, PR
Citation: P. Bhalla et al., Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT1B receptor, BR J PHARM, 133(6), 2001, pp. 891-901
Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins
Authors: Pauwels, PJ Tardif, S Colpaert, FC Wurch, T
Citation: Pj. Pauwels et al., Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins, BIOCH PHARM, 61(9), 2001, pp. 1079-1092
Optimisation of overlap extension PCR-based mutagenesis of a GC-rich DNA template: application to the human alpha(2C)-adrenoceptor cDNA
Authors: Wurch, T Lestienne, F Pauwels, PJ
Citation: T. Wurch et al., Optimisation of overlap extension PCR-based mutagenesis of a GC-rich DNA template: application to the human alpha(2C)-adrenoceptor cDNA, BIOTECH LET, 22(20), 2000, pp. 1603-1609
Agonist efficacy at the alpha(2A)-adrenoceptor : G(alpha 15) fusion protein: an analysis based on Ca2+ responses
Authors: Pauwels, PJ Finana, F Tardif, S Colpaert, FC Wurch, T
Citation: Pj. Pauwels et al., Agonist efficacy at the alpha(2A)-adrenoceptor : G(alpha 15) fusion protein: an analysis based on Ca2+ responses, N-S ARCH PH, 361(6), 2000, pp. 672-679
Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and G(alpha o) protein coexpression: Evidence for inverse agonism
Authors: Pauwels, PJ Tardif, S Wurch, T Colpaert, FC
Citation: Pj. Pauwels et al., Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and G(alpha o) protein coexpression: Evidence for inverse agonism, J PHARM EXP, 292(2), 2000, pp. 654-663
Coupling of canine serotonin 5-HT1B and 5-HT1D receptor subtypes to the formation of inositol phosphates by dual interactions with endogenous G(i/o) and recombinant G(alpha 15) proteins
Authors: Wurch, T Pauwels, PJ
Citation: T. Wurch et Pj. Pauwels, Coupling of canine serotonin 5-HT1B and 5-HT1D receptor subtypes to the formation of inositol phosphates by dual interactions with endogenous G(i/o) and recombinant G(alpha 15) proteins, J NEUROCHEM, 75(3), 2000, pp. 1180-1189
Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha(2B)-adrenoceptor-G(alpha 15) fusion proteins
Authors: Pauwels, PJ Tardif, S Finana, F Wurch, T Colpaert, FC
Citation: Pj. Pauwels et al., Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha(2B)-adrenoceptor-G(alpha 15) fusion proteins, J NEUROCHEM, 74(1), 2000, pp. 375-384
New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity
Authors: Mayer, P Brunel, P Chaplain, C Piedecoq, C Calmel, F Schambel, P Chopin, P Wurch, T Pauwels, PJ Marien, M Vidaluc, JL Imbert, T
Citation: P. Mayer et al., New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with alpha(2)-adrenoceptor antagonist activity, J MED CHEM, 43(20), 2000, pp. 3653-3664
Molecular cloning, sequence analysis and pharmacological properties of theporcine 5-HT1D receptor
Authors: Bhalla, P Sharma, HS Wurch, T Pauwels, PJ Saxena, PR
Citation: P. Bhalla et al., Molecular cloning, sequence analysis and pharmacological properties of theporcine 5-HT1D receptor, BR J PHARM, 131(5), 2000, pp. 949-957
Induction of a high-affinity ketanserin binding site at the 5-hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion
Authors: Wurch, T Palmier, C Pauwels, PJ
Citation: T. Wurch et al., Induction of a high-affinity ketanserin binding site at the 5-hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion, BIOCH PHARM, 59(9), 2000, pp. 1117-1121
alpha(2A)-adrenoceptor: G(alpha i1) protein-mediated pertussis toxin-resistant attenuation of G(s) coupling to the cyclic AMP pathway
Authors: Rauly, I Ailhaud, MC Wurch, T Pauwels, PJ
Citation: I. Rauly et al., alpha(2A)-adrenoceptor: G(alpha i1) protein-mediated pertussis toxin-resistant attenuation of G(s) coupling to the cyclic AMP pathway, BIOCH PHARM, 59(12), 2000, pp. 1531-1538
Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series ofmutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(0)alpha protein interactions
Authors: Pauwels, PJ Gouble, A Wurch, T
Citation: Pj. Pauwels et al., Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series ofmutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(0)alpha protein interactions, BIOCHEM J, 343, 1999, pp. 435-442
Modulation of 5-MT1A receptor signalling by point-mutation of cysteine(351) in the rat G(alpha o) protein
Authors: Dupuis, DS Tardif, S Wurch, T Colpaert, FC Pauwels, PJ
Citation: Ds. Dupuis et al., Modulation of 5-MT1A receptor signalling by point-mutation of cysteine(351) in the rat G(alpha o) protein, NEUROPHARM, 38(7), 1999, pp. 1035-1041
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine
Authors: John, GW Pauwels, PJ Perez, M Halazy, S Le Grand, B Verscheure, Y Valentin, JP Palmier, C Wurch, T Chopin, P Marien, M Kleven, MS Koek, W Assie, MB Carilla-Durand, E Tarayre, JP Colpaert, FC
Citation: Gw. John et al., F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine, J PHARM EXP, 290(1), 1999, pp. 83-95
G-protein activation by putative antagonists at mutant Thr(373)Lys alpha(2A) adrenergic receptors
Authors: Wurch, T Colpaert, FC Pauwels, PJ
Citation: T. Wurch et al., G-protein activation by putative antagonists at mutant Thr(373)Lys alpha(2A) adrenergic receptors, BR J PHARM, 126(4), 1999, pp. 939-948
Amino acid domains involved in constitutive activation of G-protein-coupled receptors - Review
Authors: Pauwels, PJ Wurch, T
Citation: Pj. Pauwels et T. Wurch, Amino acid domains involved in constitutive activation of G-protein-coupled receptors - Review, MOL NEUROB, 17(1-3), 1998, pp. 109-135
Chimeric receptor analysis of the ketanserin binding site in the human 5-hydroxytryptamine(1D) receptor: Importance of the second extracellular loop and fifth transmembrane domain in antagonist binding
Authors: Wurch, T Colpaert, FC Pauwels, PJ
Citation: T. Wurch et al., Chimeric receptor analysis of the ketanserin binding site in the human 5-hydroxytryptamine(1D) receptor: Importance of the second extracellular loop and fifth transmembrane domain in antagonist binding, MOLEC PHARM, 54(6), 1998, pp. 1088-1096
Risultati: 1-25 |